FAKTOR OPTIONSSCHEIN - CATALENT Share Price

DE000GQ8CR72

Real-time BOERSE MUENCHEN 01:57:06 23/05/2024 pm IST
26.78 ^EUR	+0.75%

Current month	-25.19%
1 month	-26.04%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart CATALENT, INC.

Latest news about CATALENT, INC.

Argus Downgrades Catalent to Sell From Buy	17/05	MT
Novo Nordisk Selling $5 Billion in Bonds to Back Catalent Deal	14/05	MT
Novo Nordisk Plans First Bond Sale in Two Years	14/05	MT
Novo Nordisk Plans First Bond Sale in 2 Years	13/05	MT

More news

Quotes 5-day view

Date	Price	Change
23/24/23	26.78	+0.75%
22/24/22	26.58	-1.66%
21/24/21	27.03	-5.88%
20/24/20	28.72	-0.69%
17/24/17	28.92	-3.66%

Real-time BOERSE MUENCHEN

Last update May 23, 2024 at 01:57 pm IST

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	CATALENT, INC.
Issuer	Goldman Sachs
WKN	GQ8CR7
ISIN	DE000GQ8CR72
Date issued	01/11/2023
Strike	49.47 $
Maturity	Unlimited
Parity	0.19 : 1
Emission price	8.99 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	111.7 €
Lowest since issue	2.45 €
Spread	0.59 €
Spread %	2.14%

Company Profile

Catalent, Inc. is specialized in pharmaceutical outsourcing services. The group offers solutions for the development and formulation of drugs, biological products and animal health products. Net sales break down by activity as follows: - provision of development services and clinical supply services (55.4%); - subcontracted manufacturing services (44.6%). Net sales are distributed geographically as follows: the United States (63.2%), Europe (28.7%) and other (8.1%).

Sector

More about the company

Ratings for Catalent, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Catalent, Inc.

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

54.97 USD

Average target price

63.5 USD

Spread / Average Target

+15.52%

Consensus